The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on Percutaneous closure of patent foramen ovale for recurrent migraine.
NICE has also written guidance on this procedure for:
- IPG371 Percutaneous closure of patent foramen ovale for the secondary prevention of recurrent paradoxical embolism in divers
- IPG109 - Percutaneous closure of the patent foramen ovale for the prevention of cerebral embolic stroke
The foramen ovale is a hole in the wall that divides the two upper chambers of the heart. The hole is present in the heart of a developing fetus, but normally closes up soon after the baby is born. If it fails to close it is known as a patent foramen ovale (PFO). In most people, this doesn’t cause any problems but some studies have suggested that there could be a link between having a PFO and recurrent migraines. This procedure involves passing a device through a large vessel in the groin up into the heart and closing/blocking the hole in the wall of the heart.
K16.5 Percutaneous transluminal closure of patent oval foramen with prosthesis
Y53.- Approach to organ under image control
Note: Codes within category Y53.- are used as secondary codes to classify interventions that are percutaneous and require some form of image control: if the method of image control is unspecified,Y53.9 Unspecified approach to organ under image control is assigned.
In addition the ICD-10 code Q21.1 Atrial septal defect and a code from category G43.- Migraine are assigned.
The NHS Classifications Service of NHS Connecting for Health is the central definitive source for clinical coding guidance and determines the coding standards associated with the classifications (OPCS-4 and ICD-10) to be used across the NHS. The NHS Classifications Service and NICE work collaboratively to ensure the most appropriate classification codes are provided. www.connectingforhealth.co.uk/clinicalcoding